InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the detailed record of transactions filed by Scharen-Guivel Hilda Frederique. Insider active across 1 company, notably Iradimed CORP. Cumulatively, 6 filings have been recorded. Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Scharen-Guivel Hilda Frederique is a declarant and a director of Iradimed CORP, listed on XNAS. The record shows 4 filings in total, and the 4 sampled filings run from 2023-10-23 to 2025-10-15, with the dominant transaction nature listed as Levée d'options; the buy and sell amounts shown for this sample are 0 and 0.